Literature DB >> 1387083

The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation.

M Bondesson1, C Svensson, S Linder, G Akusjärvi.   

Abstract

The adenovirus-2 E1A 289R transcription activator protein contains a 49 amino acid sequence (designated CR3) that has been suggested to represent the minimal domain required for E1A-induced activation of viral early transcription. We show here that the non-conserved carboxy-terminal E1A exon contains two interchangeable elements that are required for efficient CR3-dependent transactivation of the adenovirus E4 promoter in HeLa cells. These two elements do not encode independent transactivation functions and have been designated auxiliary regions (ARs) 1 and 2. The effects of AR1 and AR2 are not additive, suggesting that they contribute a mechanistically analogous function in transcription. Previous studies have suggested that two cellular transcription factors, ATF-2 and E4F, can function together with E1A to induce transcription of the E4 promoter. The importance of respective factors for E4 transcription has not been resolved. We find that E1A activation of E4F, but not ATF-2 (or other ATF factors), is AR1- and AR2-dependent. This result suggests that E1A induction of the E4 promoter in HeLa cells is primarily mediated by E4F.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387083      PMCID: PMC556869          DOI: 10.1002/j.1460-2075.1992.tb05413.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  A novel effect of adenovirus VA RNA1 on cytoplasmic mRNA abundance.

Authors:  C Svensson; G Akusjärvi
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

2.  Genetic dissection of the transactivating domain of the E1a 289R protein of adenovirus type 2.

Authors:  M L Fahnestock; J B Lewis
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 3.  E1a revisited: the case for multiple cooperative trans-activation domains.

Authors:  A W Braithwaite; C C Nelson; A J Bellett
Journal:  New Biol       Date:  1991-01

4.  E4F and ATF, two transcription factors that recognize the same site, can be distinguished both physically and functionally: a role for E4F in E1A trans activation.

Authors:  R J Rooney; P Raychaudhuri; J R Nevins
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

5.  Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets.

Authors:  K J Martin; J W Lillie; M R Green
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

6.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

7.  Mapping of functional domains in adenovirus E1A proteins.

Authors:  B Krippl; B Ferguson; N Jones; M Rosenberg; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses.

Authors:  H van Ormondt; J Maat; R Dijkema
Journal:  Gene       Date:  1980-12       Impact factor: 3.688

9.  Isolation and characterization of insertion mutants in E1A of adenovirus type 5.

Authors:  D S Bautista; M Hitt; J McGrory; F L Graham
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

10.  Splicing of adenovirus 2 early region 1A mRNAs is non-sequential.

Authors:  C Svensson; U Pettersson; G Akusjärvi
Journal:  J Mol Biol       Date:  1983-04-15       Impact factor: 5.469

View more
  14 in total

1.  Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A.

Authors:  R C Marcellus; H Chan; D Paquette; S Thirlwell; D Boivin; P E Branton
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter.

Authors:  M Bondesson; K Ohman; M Manervik; S Fan; G Akusjärvi
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

Authors:  J L Cook; C K Krantz; B A Routes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 4.  Adenovirus-E1A proteins transform cells by sequestering regulatory proteins.

Authors:  D S Peeper; A Zantema
Journal:  Mol Biol Rep       Date:  1993-04       Impact factor: 2.316

5.  An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter.

Authors:  M Bondesson; M Mannervik; G Akusjärvi; C Svensson
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

6.  Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis.

Authors:  R C Marcellus; J G Teodoro; T Wu; D E Brough; G Ketner; G C Shore; P E Branton
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation.

Authors:  U Schaeper; J M Boyd; S Verma; E Uhlmann; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain.

Authors:  A C Ström; P Ohlsson; G Akusjärvi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Induction of gene expression by exon 2 of the major E1A proteins of adenovirus type 5.

Authors:  J S Mymryk; S T Bayley
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function.

Authors:  Patrick J Calhoun; Allen V Phan; Jordan D Taylor; Carissa C James; Rachel L Padget; Michael J Zeitz; James W Smyth
Journal:  FASEB J       Date:  2020-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.